$207M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | KYTX Kyverna Therapeutics Inc | 4.2M | +0.0% | $38M | 18.3% |
| 2 | PYXS Pyxis Oncology Inc | 10.0M | +143.2% | $30M | 14.6% |
| 3 | TSHA Taysha Gene Therapies Inc | 723,185 | −1.9% | $25M | 11.9% |
| 4 | TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd | 2.4M | +91.1% | $16M | 7.9% |
| 5 | VIR Vir Biotechnology Inc | 1.4M | −10.9% | $14M | 6.7% |
| 6 | ALLO Allogene Therapeutics Inc | 5.3M | +270.5% | $11M | 5.3% |
| 7 | CLDX Celldex Therapeutics Inc New | 279,720 | +64.2% | $10M | 5.0% |
| 8 | EDIT Editas Medicine Inc | 3.1M | — | $10M | 4.9% |
| 9 | RARE Ultragenyx Pharmaceutical In | 289,101 | +0.0% | $10M | 4.7% |
| 10 | BLCO Bausch Plus Lomb Corp | 573,472 | +0.0% | $9M | 4.6% |
| 11 | AMGN Amgen Inc | 20,212 | +0.0% | $7M | 3.5% |
| 12 | SRRK Scholar Rock Hldg Corp | 132,500 | +0.0% | $7M | 3.5% |
| 13 | SION Sionna Therapeutics Inc | 136,000 | +0.0% | $6M | 2.9% |
| 14 | INCY Incyte Corp | 43,300 | +0.0% | $5M | 2.4% |
| 15 | CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In | 126,985 | +0.0% | $5M | 2.3% |
| 16 | INSM Insmed Inc | 28,587 | +0.0% | $3M | 1.5% |